This article talks about how the FDA voted the other day on how certain labels on birth controls, specifically Yaz, do not properly reflect the risk-benefit profile of these specific medications. Drospirenone is the questionable hormone in many oral contraceptives, such as Yasmin, Beyaz, Sayfrai, and Yaz, specifically, which is linked to people possibly developing venuous thromboembolism (VTE), or blood clots that can be found in the circulatory system. Therefore, the FDA wants to rewrite these labels of oral contraceptives that contain this hormone so people know the risks more clearly.
No comments:
Post a Comment